The promise of retinoids to fight against cancer. (Q34570078)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11902573%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

review article

1 reference

title

The promise of retinoids to fight against cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11902573%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11902573%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

Altucci L

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11902573%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

English

0 references

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11902573%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

published in

Nature Reviews Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11902573%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11902573%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11902573%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

181-193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11902573%20AND%20SRC:MED&resulttype=core&format=json

Embryonic retinoic acid synthesis is essential for early mouse post-implantation development

8 December 2019

cites work

1 reference

7 January 2021

Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain

1 reference

7 January 2021

Impaired locomotion and dopamine signaling in retinoid receptor mutant mice

1 reference

7 January 2021

Abnormal spermatogenesis in RXR beta mutant mice.

1 reference

7 January 2021

Retinoic acid receptor-β: an endogenous inhibitor of the perinatal formation of pulmonary alveoli

1 reference

7 January 2021

Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver.

1 reference

7 January 2021

Selective ablation of retinoid X receptor alpha in hepatocytes impairs their lifespan and regenerative capacity

1 reference

7 January 2021

Essential roles of retinoic acid signaling in interdigital apoptosis and control of BMP-7 expression in mouse autopods

1 reference

7 January 2021

Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL.

1 reference

7 January 2021

RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation.

1 reference

7 January 2021

Identification of 9-cis-retinoic acid, 9,13-di-cis-retinoic acid, and 14-hydroxy-4,14-retro-retinol in human plasma after liver consumption.

1 reference

7 January 2021

Intracellular Signaling by 14-hydroxy-4,14- Retro -Retinol

1 reference

7 January 2021

Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains

1 reference

7 January 2021

Combinatorial roles of the nuclear receptor corepressor in transcription and development

1 reference

7 January 2021

Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications

1 reference

7 January 2021

Mediator complexes and transcription.

1 reference

7 January 2021

The TRAP/SMCC/Mediator complex and thyroid hormone receptor function

1 reference

7 January 2021

RAR-independent RXR signaling induces t(15;17) leukemia cell maturation

1 reference

7 January 2021

Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life?

1 reference

7 January 2021

Retinoic acid rescues inner ear defects in Hoxa1 deficient mice.

1 reference

7 January 2021

Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats

1 reference

7 January 2021

Nerve growth factor acts via retinoic acid synthesis to stimulate neurite outgrowth

1 reference

7 January 2021

Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer.

1 reference

7 January 2021

Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells

1 reference

7 January 2021

Orphan receptor COUP-TF is required for induction of retinoic acid receptor beta, growth inhibition, and apoptosis by retinoic acid in cancer cells

1 reference

7 January 2021

Transcriptional silencing is defined by isoform- and heterodimer-specific interactions between nuclear hormone receptors and corepressors

1 reference

7 January 2021

Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells

1 reference

7 January 2021

Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma

1 reference

7 January 2021

v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid

1 reference

7 January 2021

Transcriptional cross-talk, the second mode of steroid hormone receptor action

1 reference

7 January 2021

Therapeutic potential of selective modulators of nuclear receptor action

1 reference

7 January 2021

A new class of retinoids with selective inhibition of AP-1 inhibits proliferation

1 reference

7 January 2021

Two distinct actions of retinoid-receptor ligands

1 reference

7 January 2021

Activation of retinoid X receptors induces apoptosis in HL-60 cell lines

1 reference

7 January 2021

Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis

1 reference

7 January 2021

Initial clinical trial of a selective retinoid X receptor ligand, LGD1069

1 reference

7 January 2021

Induction of apoptosis in ovarian carcinoma cells by AHPN/CD437 is mediated by retinoic acid receptors

1 reference

7 January 2021

Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3.

1 reference

7 January 2021

Induction of Egr-1 expression by the retinoid AHPN in human lung carcinoma cells is dependent on activated ERK1/2.

1 reference

7 January 2021

Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia

1 reference

7 January 2021

Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.

1 reference

7 January 2021

Role of the histone deacetylase complex in acute promyelocytic leukaemia

1 reference

7 January 2021

Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia

1 reference

7 January 2021

Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation.

1 reference

7 January 2021

PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR

1 reference

7 January 2021

Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers.

1 reference

7 January 2021

The function of PML in p53-dependent apoptosis

1 reference

7 January 2021

PML regulates p53 acetylation and premature senescence induced by oncogenic Ras

1 reference

7 January 2021

The transcriptional role of PML and the nuclear body

1 reference

7 January 2021

Role of PML and PML-RARalpha in Mad-mediated transcriptional repression

1 reference

7 January 2021

Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha

1 reference

7 January 2021

Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation

1 reference

7 January 2021

The TRAIL to selective tumor death

1 reference

7 January 2021

All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia

1 reference

7 January 2021

Hot on the TRAIL of acute promyelocytic leukemia

1 reference

7 January 2021

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

1 reference

7 January 2021

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

1 reference

7 January 2021

Effect of polar organic compounds on leukemic cells. Butyrate-induced partial remission of acute myelogenous leukemia in a child.

1 reference

7 January 2021

Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias?

1 reference

7 January 2021

Genomic organization and transcriptional regulation of human Apo2/TRAIL gene.

1 reference

7 January 2021

Regulation of interferon and retinoic acid-induced cell death activation through thioredoxin reductase

1 reference

7 January 2021

Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells.

1 reference

7 January 2021

c-Jun can mediate androgen receptor-induced transactivation

1 reference

7 January 2021

Glucocorticoid receptor transcriptional activity determined by spacing of receptor and nonreceptor DNA sites

1 reference

7 January 2021

A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors

1 reference

7 January 2021

Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway

1 reference

7 January 2021

Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase

1 reference

7 January 2021

The biology of acute promyelocytic leukemia

1 reference

7 January 2021

Topical tretinoin in actinic keratosis and basal cell carcinoma.

1 reference

7 January 2021

Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial

1 reference

7 January 2021

Retinoic acid redifferentiation therapy for thyroid cancer.

1 reference

7 January 2021

1 reference

7 January 2021

Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.

1 reference

7 January 2021

Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations

1 reference

7 January 2021

A phase I-II study of 9-cis retinoic acid and interferon-alpha2b in patients with advanced renal-cell carcinoma: an NCIC Clinical Trials Group study

1 reference

7 January 2021

Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma.

1 reference

7 January 2021

Retinoid chemoprevention in patients at high risk for skin cancer.

1 reference

7 January 2021

Systemic retinoid therapy

1 reference

7 January 2021

Transforming growth factor alpha (TGF-alpha) expression in dysplastic oral leukoplakia: modulation by 13-cis retinoic acid

1 reference

7 January 2021

Progressive 13-cis-retinoic acid dosage in the treatment of oral leukoplakia

1 reference

7 January 2021

13-cis-retinoic acid in the treatment of oral leukoplakia

1 reference

7 January 2021

Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin

1 reference

7 January 2021

Chemoprevention of Skin Cancer in Xeroderma Pigmentosum

1 reference

7 January 2021

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck

1 reference

7 January 2021

Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up

1 reference

7 January 2021

Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial

1 reference

7 January 2021

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

7 January 2021

Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer

1 reference

7 January 2021

13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix

1 reference

7 January 2021

Drug approval summaries: arsenic trioxide, tamoxifen citrate, anastrazole, paclitaxel, bexarotene

1 reference

7 January 2021

Emerging new therapies for cutaneous T-cell lymphoma

1 reference

7 January 2021

Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer

1 reference

7 January 2021

Safety of the synthetic retinoid fenretinide: long-term results from a controlled clinical trial for the prevention of contralateral breast cancer

1 reference

7 January 2021

Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer

1 reference

7 January 2021

ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics

1 reference

7 January 2021

Fenretinide and cancer prevention

1 reference

7 January 2021

Successful topical treatment of oral lichen planus and leukoplakias with fenretinide (4-HPR)

1 reference

7 January 2021

Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.

1 reference

7 January 2021

Retinoids for ovarian cancer prevention: laboratory data set the stage for thoughtful clinical trials

1 reference

7 January 2021

Retinoids and ovarian cancer

1 reference

7 January 2021

Fenretinide therapy in prostate cancer: effects on tissue and serum retinoid concentration

1 reference

7 January 2021

Bayesian monitoring of a phase 2 chemoprevention trial in high-risk cohorts for prostate cancer

1 reference

7 January 2021

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

7 January 2021

Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma

1 reference

7 January 2021

Identifiers

DOI

10.1038/35106036

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11902573%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

8 December 2019

1036754884

0 references

1 reference